Clinical Topic Overview
Type 2 Diabetes
Primary care physicians are on the front lines of a diabetes epidemic. Approximately 24 million people—8 percent of the U.S. population—have diabetes, and approximately one-quarter of these cases are undiagnosed. The costs of the disease, in both human and economic terms, are vast. In addition to being the seventh leading cause of death in the U.S., it is the leading cause of blindness and kidney failure and is associated with 60 percent of all amputations. Heart disease mortality and stroke risk are two to four times higher among those with diabetes than those without. In economic terms, diabetes accounts for $174 billion in direct and indirect expenditures, including lost work days and productivity in the U.S.1 As the prevalence in the U.S. and around the world continues to rise,2, 3 these costs will only continue to grow.
Primary care physicians most frequently see patients at risk for and with type 2 diabetes. As such, they are in the best position to improve diagnosis and management of patients with type 2 diabetes. However, a 2009 needs assessment of primary care physicians conducted by PennCME/BestPractice revealed the following gaps:
-
Physicians often fail to screen patients at risk for diabetes to improve rates of early diagnosis and treatment.
-
Inadequate glucose control as measured by regular administration of A1C tests and eye and foot exams to avoid and better manage complications of disease in type 2 patients.
-
Inadequate lipid management, BP control, depression screening, smoking cessation, and weight management guidance to minimize CV and CKD risks and manage other comorbid conditions in type 2 diabetes patients.
-
Physicians need to improve knowledge and understanding of treatment options, such as when to initiate insulin therapy and how to match patient needs and characteristics to the most appropriate antidiabetic agent.
-
Physicians need to address systems issues in their practices in order to provide integrated delivery of care to patients with type 2 diabetes.
-
Poor communication between patients and health care providers contributes to patient non-adherence to medication regimes, lifestyle changes and self monitoring.
References:
1Centers for Disease Control and Prevention. National diabetes fact sheet: general information and national estimates on diabetes in the United States, 2007. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. 2008. Accessed on May 23, 2010. Available at: http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2007.pdf
2Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care.2004;27:1047-53.
3Fox CS, Pencina MJ, Meigs JB, et al. Trends in the incidence of type 2 diabetes mellitus from the 1970s to the 1990s: the Framingham Heart Study. Circulation. 2006;113:2914-
Type 2 Diabetes Resources from Penn CME/BestPractice
| Performance Improvement | Patient Resource Center |
| Staff Resource Center | Extended Resources |
CME Content - Type 2 Diabetes
Hot Topics
Common Errors in T2D Management: Picking the Right Oral MedicationCommon Errors in T2D Management: Misuse of Insulin SecretagoguesCommon Errors in T2D Management: Pushing for Weight Loss—But Not Too MuchCommon Errors in T2D Management: Metformin and Renal FailureCommon Errors in T2D Management: Delaying the Start of InsulinCommon Errors in T2D Management: Overuse of premixed insulinsCommon Errors in T2D Management: Failure to Distinguish Between T2DM and T1DMCommon Errors in T2D Management: Problems with Blood Glucose Self-Monitoring
Breaking Diabetes News
-
PHILADELPHIA -- Prediabetic patients with obstructive sleep apnea had significant improvement in glucose levels after effective treatment with continuous positive airway pressure (CPAP), a small clinical trial showed.
-
The mystery of why a drug for one autoimmune disease can cause another may have been solved. Also this week: a new oral nimodipine formulation aimed at reducing medication errors.
-
As concerns escalate over the potential risks of glucagon-like peptide-1 (GLP-1)-based therapies, a diabetes journal hosted a point-counterpoint debate between the researchers who have been the leading voices on each side of the issue.
-
Healthcare reform in Massachusetts did not increase overall use of inpatient resources, but other states may not be so lucky, researchers found.
-
ALLDogs, Cats May Be Heart Healthy, AHA Says | Steady Warfarin Best for Cardiac Device Surgery | If Job Stress Mounts, Healthy Living May Be Lifesaver | Cocaine Use May Make Brain Bleeds Deadlier | Women MI Patients Sicker Than Men
-
High LDL cholesterol levels were a weak predictor of myocardial infarction risk in patients with chronic kidney disease, a study found.
-
Heart failure or heart attack patients should be closely watched for at least a year post-discharge because the risk for rehospitalization or death remains elevated during that time, researchers suggested.
-
That middle-age bulge can damage the heart, but a sustained improvement in fitness level reduces the risk of heart failure hospitalization over time, researchers found.
-
A review of published studies investigating a possible link between sugar-sweetened drinks and obesity found that studies funded by the beverage industry were likely to find little evidence that sodas and juices fuel obesity.
-
WASHINGTON -- Evidence is insufficient to conclude that lowering daily sodium intake below 2,300 mg per day either harms or improves cardiovascular outcomes and all-cause mortality, the Institute of Medicine said Tuesday.
